Lactococcus lactis provides an efficient platform for production of disulfide-rich recombinant proteins from Plasmodium falciparum

The GMZ2 malaria vaccine: from concept to efficacy in humans

(2017) Michael Theisen et al.   Expert Review of Vaccines

Antibody responses to two new Lactococcus lactis-produced recombinant Pfs48/45 and Pfs230 proteins increase with age in malaria patients living in the Central Region of Ghana

(2017) Festus K. Acquah et al.   MALARIA JOURNAL

Construct design, production, and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccine

(2017) Susheel K. Singh et al.   Microbial Cell Factories

Efficient soluble expression of disulfide bonded proteins in the cytoplasm of Escherichia coli in fed-batch fermentations on chemically defined minimal media

(2017) Anna Gąciarz et al.   Microbial Cell Factories

Expression, Purification and Characterization of GMZ2’.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite

(2017) Ulrik H. Mistarz et al.   PHARMACEUTICAL RESEARCH

The apicomplexan glideosome and adhesins – Structures and function

(2015) Lauren E. Boucher et al.   JOURNAL OF STRUCTURAL BIOLOGY

A Plasmodium falciparum 48/45 single epitope R0.6C subunit protein elicits high levels of transmission blocking antibodies

(2015) Susheel K. Singh et al.   VACCINE

Insights into the Immunological Properties of Intrinsically Disordered Malaria Proteins Using Proteome Scale Predictions

(2015) Andrew J. Guy et al.   PLoS One

Proteins without unique 3D structures: Biotechnological applications of intrinsically unstable/disordered proteins

(2014) Vladimir N. Uversky   Biotechnology Journal

New antigens for a multicomponent blood-stage malaria vaccine

(2014) F. H. Osier et al.   Science Translational Medicine

A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages

(2014) Michael Theisen et al.   VACCINE

Breadth of Anti-Merozoite Antibody Responses Is Associated With the Genetic Diversity of Asymptomatic Plasmodium falciparum Infections and Protection Against Clinical Malaria

(2013) Josea Rono et al.   CLINICAL INFECTIOUS DISEASES

Identification and Prioritization of Merozoite Antigens as Targets of Protective Human Immunity to Plasmodium falciparum Malaria for Vaccine and Biomarker Development

(2013) J. S. Richards et al.   JOURNAL OF IMMUNOLOGY

A Library of Functional Recombinant Cell-surface and SecretedP. falciparumMerozoite Proteins

(2013) Cécile Crosnier et al.   MOLECULAR & CELLULAR PROTEOMICS

Development and evaluation of a multiplex screening assay for Plasmodium falciparum exposure

(2012) Micha Phill Grønholm Jepsen et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Systematic analysis of natural antibody responses to P. falciparum merozoite antigens by protein arrays

(2012) Yan-Ting Fan et al.   Journal of Proteomics

Disulfide Bond Formation in the Mammalian Endoplasmic Reticulum

(2012) N. J. Bulleid   Cold Spring Harbor Perspectives in Biology

Production of disulfide-bonded proteins in Escherichia coli

(2011) Mehmet Berkmen   PROTEIN EXPRESSION AND PURIFICATION

Lactococcus lactis-based vaccines from laboratory bench to human use: An overview

(2011) Mohammed Bahey-El-Din   VACCINE

Detergent binding explains anomalous SDS-PAGE migration of membrane proteins

(2009) Arianna Rath et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children

(2008) Daniel Dodoo et al.   MALARIA JOURNAL

Bacterial species exhibit diversity in their mechanisms and capacity for protein disulfide bond formation

(2008) R. J. Dutton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA